News Detail
New Delhi, 21 May 2024: The Indian Council of Medical Research (ICMR) on Monday distanced itself from BHU's study on Covaxin and called it "poorly designed". ICMR Director General Dr Rajiv Bahl wrote a letter to the authors of the paper and editor of the journal to immediately re......
View Details
Source : Business Today
ICMR
Covaxin
BHU Study
Side Effects
Covaxin Controversy
Vaccine Safety
AESIs
Bharat Biotech
COVID-19 Vaccine
Vaccine Adverse Events
Covaxin Side Effects
Dr Rajiv Bahl
Springer Nature Journal
Medical Research
Adverse Events of Special Interest
Covishield
AstraZeneca
Vaccine-Associated Incidents
Ministry of Health India
Long-Term Vaccine Safety
Related News
- UT man duped of Rs 1.4 lakh in fake Patanjali treatment scam (13-01-2025)
- Kidney, liver damage in 3 new moms given faulty drip (13-01-2025)
- WB govt bans 10 intravenous fluids in hospitals for patient safety (13-01-2025)
- 15 lakh annual surgical site infections in India:ICMR study (13-01-2025)
- NCB and police seized Narcotic capsules in Hindaun City, one arrested (12-01-2025)
- Assam: Massive consignment of illicit cough syrup seized in Guwahati (12-01-2025)
- Police probe company behind tramadol diversion in Punjab (12-01-2025)
- ACB caught UP Pharmacy Council contract worker red-handed accepting bribe of Rs 5,000 (12-01-2025)
- Medical shop running without license, medicines worth 50 thousand seized (12-01-2025)
- Drug business under the guise of medicine shop: 600 injections seized (12-01-2025)